In a recently available study, we’ve shown that folliculostellate cells in the ovine pituitary display overt ultrastructural changes through the entire annual reproductive cycle with an increase of cell size, greater amount of hard endoplasmic reticulum, and improved amount of intercellular adherens junctions through the long days of summer, in the non-breeding season [13]; (Fig

In a recently available study, we’ve shown that folliculostellate cells in the ovine pituitary display overt ultrastructural changes through the entire annual reproductive cycle with… Read More »In a recently available study, we’ve shown that folliculostellate cells in the ovine pituitary display overt ultrastructural changes through the entire annual reproductive cycle with an increase of cell size, greater amount of hard endoplasmic reticulum, and improved amount of intercellular adherens junctions through the long days of summer, in the non-breeding season [13]; (Fig

To show whether capillary tube-like buildings (Figure 4(c)) had lumina, we used reflective confocal microscopic analysis

To show whether capillary tube-like buildings (Figure 4(c)) had lumina, we used reflective confocal microscopic analysis. 3D matrices but synergistically regulate sprout angiogenesis differentially. Thus… Read More »To show whether capillary tube-like buildings (Figure 4(c)) had lumina, we used reflective confocal microscopic analysis

Preclinical trials with tofacitinib showed significant improvement in experimental models of autoimmunity and organ transplantation (34C36) Currently, tofacitinib is approved in the USA, Japan, Switzerland, Russia, Argentina, Kuwait and the United Arab Emirates for the treatment of patients with RA

Preclinical trials with tofacitinib showed significant improvement in experimental models of autoimmunity and organ transplantation (34C36) Currently, tofacitinib is approved in the USA, Japan, Switzerland,… Read More »Preclinical trials with tofacitinib showed significant improvement in experimental models of autoimmunity and organ transplantation (34C36) Currently, tofacitinib is approved in the USA, Japan, Switzerland, Russia, Argentina, Kuwait and the United Arab Emirates for the treatment of patients with RA

We compared ramifications of Rho kinase inhibitors, Y\27632 and Fasudil (HA\1077) to PAF\mediated responses, in soft muscle cells from pulmonary arteries (SMC\PA) and blood vessels (SMC\PV) to get insight into regulatory pathways occurring in pulmonary arteries and blood vessels of developing foetal lamb lungs

We compared ramifications of Rho kinase inhibitors, Y\27632 and Fasudil (HA\1077) to PAF\mediated responses, in soft muscle cells from pulmonary arteries (SMC\PA) and blood vessels… Read More »We compared ramifications of Rho kinase inhibitors, Y\27632 and Fasudil (HA\1077) to PAF\mediated responses, in soft muscle cells from pulmonary arteries (SMC\PA) and blood vessels (SMC\PV) to get insight into regulatory pathways occurring in pulmonary arteries and blood vessels of developing foetal lamb lungs